These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 2105510)
21. [The use of flumazenil in the treatment of hepatic encephalopathy secondary to acute liver failure. A report of 2 cases]. Díaz de León-Ponce M; Eid-Lidt G; Castañón-González JA; Deseaño-Estudillo JL; Reyes B Gac Med Mex; 1993; 129(5):347-50. PubMed ID: 7926421 [No Abstract] [Full Text] [Related]
23. Reversal of hepatic coma with flumazenil with improvement in visual evoked potentials. Burke DA; Mitchell KW; al Mardini H; Record CO Lancet; 1988 Aug; 2(8609):505-6. PubMed ID: 2900422 [No Abstract] [Full Text] [Related]
24. Benzodiazepine receptor antagonists for acute and chronic hepatic encephalopathy. Als-Nielsen B; Kjaergard LL; Gluud C Cochrane Database Syst Rev; 2001; (4):CD002798. PubMed ID: 11687160 [TBL] [Abstract][Full Text] [Related]
25. Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy. Goh ET; Andersen ML; Morgan MY; Gluud LL Cochrane Database Syst Rev; 2017 Jul; 7(7):CD002798. PubMed ID: 28745801 [TBL] [Abstract][Full Text] [Related]
27. Is flumazenil an alternative for the treatment of hepatic encephalopathy? Reyes D; Barrera F Medwave; 2017 Dec; 17(9):e7113. PubMed ID: 29286356 [TBL] [Abstract][Full Text] [Related]
28. Flumazenil for hepatic coma: the elusive wake-up call? Sterling RK; Shiffman ML; Schubert ML Gastroenterology; 1994 Oct; 107(4):1204-5. PubMed ID: 7926473 [No Abstract] [Full Text] [Related]
29. Successful long-term treatment of portal-systemic encephalopathy by the benzodiazepine antagonist flumazenil. Ferenci P; Grimm G; Meryn S; Gangl A Gastroenterology; 1989 Jan; 96(1):240-3. PubMed ID: 2491822 [TBL] [Abstract][Full Text] [Related]
30. Flumazenil therapy for hepatic encephalopathy. A double-blind cross over study. Van der Rijt CC; Schalm SW; Meulstee J; Stijnen T Gastroenterol Clin Biol; 1995; 19(6-7):572-80. PubMed ID: 7590022 [TBL] [Abstract][Full Text] [Related]
31. [Chronic hepatic encephalopathy treated by long-term intravenous administration of flumazenil in ambulatory care]. Péroux JL; Paolini O; Tran A; Frappa B; Rampal P Gastroenterol Clin Biol; 1996 Feb; 20(1):106-8. PubMed ID: 8734316 [TBL] [Abstract][Full Text] [Related]
32. Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans. Bansky G; Meier PJ; Riederer E; Walser H; Ziegler WH; Schmid M Gastroenterology; 1989 Sep; 97(3):744-50. PubMed ID: 2546850 [TBL] [Abstract][Full Text] [Related]
35. [Current possibilities in the therapy of hepatic encephalopathy]. Meier PJ; Bansky G Schweiz Med Wochenschr; 1990 Apr; 120(15):553-6. PubMed ID: 2159659 [TBL] [Abstract][Full Text] [Related]
36. Flumazenil vs. placebo in hepatic encephalopathy in patients with cirrhosis: a meta-analysis. Goulenok C; Bernard B; Cadranel JF; Thabut D; Di Martino V; Opolon P; Poynard T Aliment Pharmacol Ther; 2002 Mar; 16(3):361-72. PubMed ID: 11876688 [TBL] [Abstract][Full Text] [Related]
37. The effects of benzodiazepine-receptor antagonists and partial inverse agonists on acute hepatic encephalopathy in the rat. Bosman DK; van den Buijs CA; de Haan JG; Maas MA; Chamuleau RA Gastroenterology; 1991 Sep; 101(3):772-81. PubMed ID: 1650320 [TBL] [Abstract][Full Text] [Related]
38. Role of Flumazenil in the Management of Hepatic Encephalopathy. Agrawal A; Diez A; Bajaj D Am J Ther; 2020; 27(6):e629-e630. PubMed ID: 31241495 [No Abstract] [Full Text] [Related]